<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03050372</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00055979</org_study_id>
    <nct_id>NCT03050372</nct_id>
  </id_info>
  <brief_title>Study of Low Field Magnetic Stimulation (LFMS) on Measures of Sleep</brief_title>
  <official_title>Double-Blind, Sham-Controlled Crossover Pilot Study of Low Field Magnetic Stimulation (LFMS) on Subjective and Objective Measures of Sleep</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tal Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Participants will be recruited and screened through ongoing studies in the sleep and anxiety
      disorders clinic. Participants with insomnia will be consented to complete several
      questionnaires, undergo a brief physical exam, provide a urinalysis, and undergo 5 nights of
      active or sham Low Field Magnetic Stimulation (LFMS) followed by an overnight sleep study.
      Each of the two treatment conditions (active versus sham) will be conducted on two
      consecutive nights. There will be no more than 7 days between the adaptation night and the
      first treatment condition and no more than 7 nights between each of the two-night treatment
      conditions . Thus, each participant who completes the full study will spend a total of 5
      nights in the sleep laboratory and the time interval from the first adaptation night to
      completion of the study may range from 5-19 days for any particular individual.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Funding no longer available
  </why_stopped>
  <start_date>November 2016</start_date>
  <completion_date type="Actual">December 2018</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sleep Onset Latency (SOL) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</measure>
    <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
    <description>SOL is the time of transition from wake to sleep (non-REM S1) measured in minutes; a validated objective measure extracted directly from full-night polysomnography (PSG). SOL of 0-5min is associated with severe sleep deprivation; 5-10min is moderate sleep debt; 10-15min indicates mild sleep debt; 15-20min is little-to-no sleep debt; and &gt;20min is considered to be associated with no sleep debt.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wake After Sleep Onset (WASO) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</measure>
    <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
    <description>Total time awake after initial sleep onset in minutes; validated objective measure directly extracted from polysomnography (PSG); we average measures from both consecutive nights under each of the two interventions (Sham or Active LFMS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Sleep Time (TST) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</measure>
    <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
    <description>Total Sleep Time is the total time spent sleeping (non-wake stages S1-S5) in minutes; validated objective measure directly extracted from polysomnography (PSG).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep Efficiency (SE) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</measure>
    <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
    <description>Sleep Efficiency (SE) is an objective measure of sleep quality derived from polysomnography (PSG); it is a unitless measure defined as the total sleep time (TST) divided by total time in bed (TiB); it can theoretically range from 0 (no sleep at all) to 1 (slept the entire time in bed). Values close to zero indicate very little time spent sleeping while values close to one indicate a large sleep utilization while in bed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ease of Sleep (EOS) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</measure>
    <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
    <description>Ease of Sleep (EOS) is assessed after each night as a subjective measure; participants self-rate their ease to fall asleep on a visual analog scale 0-100mm where 0mm is associated with not easy at all (no sleep) and 100mm is associated with no problems to fall asleep. EOS is a proxy measure for a participants sleepiness.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MUSC Sleep Quality Score (SQS) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</measure>
    <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
    <description>MUSC Sleep Quality Score (SQS) is assessed after each night as a subjective measure; participants self-rate their perceived sleep quality on a 0-6 scale where 0 is associated with extremely poor sleep quality and 6 is associated with extremely good sleep quality.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Awakenings (#Awake) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</measure>
    <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
    <description>Number of Awakenings (#awake) is the integer number of nocturnal awakenings after initial sleep onset, i.e. a count.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</measure>
    <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
    <description>Participants rate after each night how fatigued they feel on a 0-100mm continuous scale; 0mm not at all; 100mm very/a lot.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</measure>
    <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
    <description>Participants rate after each night their ability to concentrate on a 0-100mm continuous scale; 0mm not at all; 100mm very/a lot. This is a subjective proxy measure for a restorative sleep / sleep quality.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Insomnia, Primary</condition>
  <arm_group>
    <arm_group_label>Active Low Field Magnetic Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LFMS - Active</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Low Field Magnetic Stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>LFMS - Sham</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LFMS - Active</intervention_name>
    <description>A non-invasive form of brain stimulation administered from a device resembling a bird cage. The device covers the top part of the head for the duration of stimulation (in the current study, 20 minutes)</description>
    <arm_group_label>Active Low Field Magnetic Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LFMS - Sham</intervention_name>
    <description>A simulation of the LFMS-Active intervention, using the same device that produces a sound similar to the sound made by the device during the active treatment, for a similar duration (in the current study, 20 minutes)</description>
    <arm_group_label>Sham Low Field Magnetic Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Insomnia diagnosis per DSM-5 criteria

          -  Performing tasks in a timely manner (compared to the person's usual level of
             performance)

          -  Pittsburgh Sleep Quality Index (PSQI) &gt; 6 and one of the following:

          -  Sleep Efficiency &lt; 85% (per Consensus Sleep Diary)

          -  Insomnia Severity Index (ISI) score &gt; 15

          -  Sleep latency (subjective) and/or time awake after sleep onset (subjective) &gt;30
             minutes.

          -  Not currently depressed (previous major depressive episodes and current antidepressant
             medication permitted as long as remission and current medication dosage has been
             stable for â‰¥ 1 month).

          -  Willing to refrain from alcohol for twenty-four hours before presenting to sleep lab
             for sleep studies

          -  BMI &gt; 18 and &lt; 50 kg/m2

        Exclusion Criteria:

          -  Current major depressive episode

          -  Current substance-induced depressive disorder

          -  Self-reported use of benzodiazepines or hypnotic drugs in last two weeks

          -  Self-reported use of marijuana in previous 72 hours

          -  Alcohol Use Disorders Identification Test (AUDIT) score &gt; 10

          -  Fagerstrom Test for Nicotine Dependence (FTND) score &gt; 4

          -  Insomnia limited to early morning awakening (without difficulty initiating or
             maintaining sleep),

          -  Narcolepsy

          -  Seizure Disorder (not including childhood febrile seizures)

          -  Recent treatment with anticonvulsant medications

          -  Obstructive or central sleep apnea

          -  Circadian rhythm sleep-wake disorders

          -  Recurrent isolated sleep paralysis

          -  Current substance-induced insomnia

          -  Chronic pain disorder

          -  Daily Caffeine Consumption &gt; 500 mg/d (Uhde, 1989)

          -  Restless legs syndrome

          -  Periodic Leg Movement Disorder

          -  Benzodiazepines or antipsychotic medications during past 30 days

          -  Presence of drugs of abuse (excluding marijuana, urinalysis)

          -  Pregnancy or plans to become pregnant

          -  History of severe allergic reactions to adhesive tape

          -  History of neurological disorder

          -  Conductive, ferromagnetic or other magnetic-sensitive metals in the head, neck, chest,
             upper arms, or any area that will be within 18 inches of the treatment coil.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Uhde, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>December 16, 2016</study_first_submitted>
  <study_first_submitted_qc>February 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2017</study_first_posted>
  <results_first_submitted>December 31, 2019</results_first_submitted>
  <results_first_submitted_qc>February 12, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 13, 2020</results_first_posted>
  <last_update_submitted>February 12, 2020</last_update_submitted>
  <last_update_submitted_qc>February 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>This process is still being discussed by investigators. Once plan is complete it will likely include protocol and primary outcome measures which may be accessed through peer reviewed publications.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 15, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/72/NCT03050372/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Eligibility screening was completed over the phone by trained sleep personnel; sleep laboratory is located at the Medical University of South Carolina's Institute of Psychiatry at 67 President St., Charleston S.C. This is a crossover study; each participant is exposed to both active and sham conditions.</recruitment_details>
      <pre_assignment_details>N=209 subjects screened from 07/2016-07/2017; N=193 participants were excluded prior to PSG because they declined to participate (N=49), did not meet the age criterion (N=28), did not meet the sleep criterion (N=61), had co-morbid psychiatric disorders (N=42), or for other reasons (N=13); N=4 excluded after consent due to medication/baby/no-show.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Active Low Field Magnetic Stimulation (LFMS), Then Sham LFMS</title>
          <description>Adaptation Night; then two consecutive nights of Active LFMS; after washout two consecutive nights of Sham LFMS
LFMS - Active: A non-invasive form of brain stimulation administered from a device resembling a bird cage. The device covers the top part of the head for the duration of stimulation (in the current study, 20 minutes); then participants complete a full night of sleep in the sleep lab
LFMS - Sham: A simulation of the LFMS-Active intervention, using the same device that produces a sound similar to the sound made by the device during the active treatment, for a similar duration (in the current study, 20 minutes); then participants complete a full night of sleep in the sleep lab</description>
        </group>
        <group group_id="P2">
          <title>Sham Low Field Magnetic Stimulation (LFMS), Then Active LFMS</title>
          <description>Adaptation Night; then two consecutive nights of Sham LFMS; after washout followed by two consecutive nights of Active LFMS
LFMS - Active: A non-invasive form of brain stimulation administered from a device resembling a bird cage. The device covers the top part of the head for the duration of stimulation (in the current study, 20 minutes); then participants complete a full night of sleep in the sleep lab
LFMS - Sham: A simulation of the LFMS-Active intervention, using the same device that produces a sound similar to the sound made by the device during the active treatment, for a similar duration (in the current study, 20 minutes); then participants complete a full night of sleep in the sleep lab</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Adaptation Night (Night #1 PSG)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5">N=1 subject removed from study due to mild sleep apnea during adaptation night</participants>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>First Intervention (Nights #2 and #3)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention (Nights #4 and #5)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5">N=1 subject (blind only broken after double-blind analysis) moved out off State; lost to study</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Study Participants</title>
          <description>Participants are randomized to receive either two consecutive nights of &quot;Active Low Field Magnetic Stimulation&quot; followed by &quot;Sham Low Field Magnetic Stimulation&quot; or vice versa.
Active Low Field Magnetic Stimulation LFMS - Active: A non-invasive form of brain stimulation administered from a device resembling a bird cage. The device covers the top part of the head for the duration of stimulation (in the current study, 20 minutes)
Sham Low Field Magnetic Stimulation LFMS - Sham: A simulation of the LFMS-Active intervention, using the same device that produces a sound similar to the sound made by the device during the active treatment, for a similar duration (in the current study, 20 minutes)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.58" spread="8.512"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>inch</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.83" spread="3.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>lbm (pound mass)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="184.83" spread="35.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>PSQI (Pittsburgh Sleep Quality Inventory)</title>
          <description>Pittsburgh Sleep Quality Inventory (PSQI) is a well established 10-question questionnaire (24 items incl. sub-questions 5a-j and 10a-e) that assesses subjective sleep quality, -latency, -duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, daytime dysfunction. Individual items' responses are in the range of 0-3; a total PSQI score is derived by first deriving 7 equally weighted components from all 24 responses; each component is in the range of 0-3, resulting in a total score (sum of all components) of 0-21; a total PSQI score of &gt;=5 is associated with poor sleep.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11.58" spread="2.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Sleep Onset Latency (SOL) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
        <description>SOL is the time of transition from wake to sleep (non-REM S1) measured in minutes; a validated objective measure extracted directly from full-night polysomnography (PSG). SOL of 0-5min is associated with severe sleep deprivation; 5-10min is moderate sleep debt; 10-15min indicates mild sleep debt; 15-20min is little-to-no sleep debt; and &gt;20min is considered to be associated with no sleep debt.</description>
        <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
        <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
        <group_list>
          <group group_id="O1">
            <title>Active Low Field Magnetic Stimulation</title>
            <description>LFMS - Active
LFMS - Active: A non-invasive form of brain stimulation administered from a device resembling a bird cage. The device covers the top part of the head for the duration of stimulation (in the current study, 20 minutes)</description>
          </group>
          <group group_id="O2">
            <title>Sham Low Field Magnetic Stimulation</title>
            <description>LFMS - Sham
LFMS - Sham: A simulation of the LFMS-Active intervention, using the same device that produces a sound similar to the sound made by the device during the active treatment, for a similar duration (in the current study, 20 minutes)</description>
          </group>
        </group_list>
        <measure>
          <title>Sleep Onset Latency (SOL) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
          <description>SOL is the time of transition from wake to sleep (non-REM S1) measured in minutes; a validated objective measure extracted directly from full-night polysomnography (PSG). SOL of 0-5min is associated with severe sleep deprivation; 5-10min is moderate sleep debt; 10-15min indicates mild sleep debt; 15-20min is little-to-no sleep debt; and &gt;20min is considered to be associated with no sleep debt.</description>
          <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline SOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.35" spread="25.95"/>
                    <measurement group_id="O2" value="43.35" spread="25.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intervention LFMS; two-night average in each arm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.88" spread="40.03"/>
                    <measurement group_id="O2" value="46.35" spread="34.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline SOL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.53" spread="31.67"/>
                    <measurement group_id="O2" value="3.00" spread="22.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of SOL for active/sham LFMS are equal; Ha: Means differ
Note this paired t-test is equivalent to:
H0: Mean changes from Baseline SOL for active/sham LFMS are equal Ha: Means differ</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%.</non_inferiority_desc>
            <p_value>0.329</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of SOL for Baseline and Active LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline SOL for Active LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.321</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of SOL for Baseline and Sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline SOL for Sham LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.687</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Wake After Sleep Onset (WASO) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
        <description>Total time awake after initial sleep onset in minutes; validated objective measure directly extracted from polysomnography (PSG); we average measures from both consecutive nights under each of the two interventions (Sham or Active LFMS)</description>
        <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
        <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
        <group_list>
          <group group_id="O1">
            <title>Active Low Field Magnetic Stimulation</title>
            <description>LFMS - Active
LFMS - Active: A non-invasive form of brain stimulation administered from a device resembling a bird cage. The device covers the top part of the head for the duration of stimulation (in the current study, 20 minutes)</description>
          </group>
          <group group_id="O2">
            <title>Sham Low Field Magnetic Stimulation</title>
            <description>LFMS - Sham
LFMS - Sham: A simulation of the LFMS-Active intervention, using the same device that produces a sound similar to the sound made by the device during the active treatment, for a similar duration (in the current study, 20 minutes)</description>
          </group>
        </group_list>
        <measure>
          <title>Wake After Sleep Onset (WASO) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
          <description>Total time awake after initial sleep onset in minutes; validated objective measure directly extracted from polysomnography (PSG); we average measures from both consecutive nights under each of the two interventions (Sham or Active LFMS)</description>
          <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline WASO</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.85" spread="78.41"/>
                    <measurement group_id="O2" value="80.85" spread="78.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sham or Active LFMS (two-night average)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.80" spread="46.87"/>
                    <measurement group_id="O2" value="56.00" spread="31.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline WASO</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.05" spread="41.69"/>
                    <measurement group_id="O2" value="24.85" spread="59.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of WASO for active/sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to:
H0: Mean changes from Baseline WASO for active/sham LFMS are equal Ha: Means differ</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.925</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of WASO for Baseline and Active LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline WASO for Active LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.08</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of WASO for Baseline and Sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline WASO for Sham LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.221</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total Sleep Time (TST) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
        <description>Total Sleep Time is the total time spent sleeping (non-wake stages S1-S5) in minutes; validated objective measure directly extracted from polysomnography (PSG).</description>
        <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
        <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
        <group_list>
          <group group_id="O1">
            <title>Active Low Field Magnetic Stimulation</title>
            <description>LFMS - Active
LFMS - Active: A non-invasive form of brain stimulation administered from a device resembling a bird cage. The device covers the top part of the head for the duration of stimulation (in the current study, 20 minutes)</description>
          </group>
          <group group_id="O2">
            <title>Sham Low Field Magnetic Stimulation</title>
            <description>LFMS - Sham
LFMS - Sham: A simulation of the LFMS-Active intervention, using the same device that produces a sound similar to the sound made by the device during the active treatment, for a similar duration (in the current study, 20 minutes)</description>
          </group>
        </group_list>
        <measure>
          <title>Total Sleep Time (TST) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
          <description>Total Sleep Time is the total time spent sleeping (non-wake stages S1-S5) in minutes; validated objective measure directly extracted from polysomnography (PSG).</description>
          <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline TST</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="359.60" spread="86.60"/>
                    <measurement group_id="O2" value="359.60" spread="86.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sham or Active LFMS (two-night average)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="370.40" spread="80.96"/>
                    <measurement group_id="O2" value="388.53" spread="73.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline TST</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.80" spread="60.50"/>
                    <measurement group_id="O2" value="28.93" spread="82.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of TST for active/sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to:
H0: Mean changes from Baseline TST for active/sham LFMS are equal Ha: Means differ</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.197</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of TST for Baseline and Active LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline TST for Active LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.586</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of TST for Baseline and Sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline TST for Sham LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.298</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sleep Efficiency (SE) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
        <description>Sleep Efficiency (SE) is an objective measure of sleep quality derived from polysomnography (PSG); it is a unitless measure defined as the total sleep time (TST) divided by total time in bed (TiB); it can theoretically range from 0 (no sleep at all) to 1 (slept the entire time in bed). Values close to zero indicate very little time spent sleeping while values close to one indicate a large sleep utilization while in bed.</description>
        <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
        <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
        <group_list>
          <group group_id="O1">
            <title>Active Low Field Magnetic Stimulation</title>
            <description>LFMS - Active
LFMS - Active: A non-invasive form of brain stimulation administered from a device resembling a bird cage. The device covers the top part of the head for the duration of stimulation (in the current study, 20 minutes)</description>
          </group>
          <group group_id="O2">
            <title>Sham Low Field Magnetic Stimulation</title>
            <description>LFMS - Sham
LFMS - Sham: A simulation of the LFMS-Active intervention, using the same device that produces a sound similar to the sound made by the device during the active treatment, for a similar duration (in the current study, 20 minutes)</description>
          </group>
        </group_list>
        <measure>
          <title>Sleep Efficiency (SE) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
          <description>Sleep Efficiency (SE) is an objective measure of sleep quality derived from polysomnography (PSG); it is a unitless measure defined as the total sleep time (TST) divided by total time in bed (TiB); it can theoretically range from 0 (no sleep at all) to 1 (slept the entire time in bed). Values close to zero indicate very little time spent sleeping while values close to one indicate a large sleep utilization while in bed.</description>
          <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
          <units>unitless ratio (0 to 1)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline SE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.72" spread="0.16"/>
                    <measurement group_id="O2" value="0.72" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sham or Active LFMS (two-night average)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.77" spread="0.11"/>
                    <measurement group_id="O2" value="0.79" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline SE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.11"/>
                    <measurement group_id="O2" value="0.07" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of SE for active/sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to:
H0: Mean changes from Baseline SE for active/sham LFMS are equal Ha: Means differ</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.424</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of SE for Baseline and Active LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline SE for Active LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.210</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of SE for Baseline and Sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline SE for Sham LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.190</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ease of Sleep (EOS) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
        <description>Ease of Sleep (EOS) is assessed after each night as a subjective measure; participants self-rate their ease to fall asleep on a visual analog scale 0-100mm where 0mm is associated with not easy at all (no sleep) and 100mm is associated with no problems to fall asleep. EOS is a proxy measure for a participants sleepiness.</description>
        <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
        <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
        <group_list>
          <group group_id="O1">
            <title>Active Low Field Magnetic Stimulation</title>
            <description>LFMS - Active
LFMS - Active: A non-invasive form of brain stimulation administered from a device resembling a bird cage. The device covers the top part of the head for the duration of stimulation (in the current study, 20 minutes)</description>
          </group>
          <group group_id="O2">
            <title>Sham Low Field Magnetic Stimulation</title>
            <description>LFMS - Sham
LFMS - Sham: A simulation of the LFMS-Active intervention, using the same device that produces a sound similar to the sound made by the device during the active treatment, for a similar duration (in the current study, 20 minutes)</description>
          </group>
        </group_list>
        <measure>
          <title>Ease of Sleep (EOS) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
          <description>Ease of Sleep (EOS) is assessed after each night as a subjective measure; participants self-rate their ease to fall asleep on a visual analog scale 0-100mm where 0mm is associated with not easy at all (no sleep) and 100mm is associated with no problems to fall asleep. EOS is a proxy measure for a participants sleepiness.</description>
          <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
          <units>units on a scale (0-100mm)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline EOS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.30" spread="30.99"/>
                    <measurement group_id="O2" value="63.30" spread="30.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sham or Active LFMS (two-night average)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.95" spread="26.47"/>
                    <measurement group_id="O2" value="47.70" spread="17.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline EOS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.35" spread="25.70"/>
                    <measurement group_id="O2" value="-15.60" spread="26.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of EOS for active/sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to:
H0: Mean changes from Baseline EOS for active/sham LFMS are equal Ha: Means differ</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.535</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of EOS for Baseline and Active LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline EOS for Active LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.196</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of EOS for Baseline and Sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline EOS for Sham LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.092</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>MUSC Sleep Quality Score (SQS) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
        <description>MUSC Sleep Quality Score (SQS) is assessed after each night as a subjective measure; participants self-rate their perceived sleep quality on a 0-6 scale where 0 is associated with extremely poor sleep quality and 6 is associated with extremely good sleep quality.</description>
        <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
        <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
        <group_list>
          <group group_id="O1">
            <title>Active Low Field Magnetic Stimulation</title>
            <description>LFMS - Active
LFMS - Active: A non-invasive form of brain stimulation administered from a device resembling a bird cage. The device covers the top part of the head for the duration of stimulation (in the current study, 20 minutes)</description>
          </group>
          <group group_id="O2">
            <title>Sham Low Field Magnetic Stimulation</title>
            <description>LFMS - Sham
LFMS - Sham: A simulation of the LFMS-Active intervention, using the same device that produces a sound similar to the sound made by the device during the active treatment, for a similar duration (in the current study, 20 minutes)</description>
          </group>
        </group_list>
        <measure>
          <title>MUSC Sleep Quality Score (SQS) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
          <description>MUSC Sleep Quality Score (SQS) is assessed after each night as a subjective measure; participants self-rate their perceived sleep quality on a 0-6 scale where 0 is associated with extremely poor sleep quality and 6 is associated with extremely good sleep quality.</description>
          <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
          <units>score on a scale (0-6)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline SQS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.90" spread="0.74"/>
                    <measurement group_id="O2" value="1.90" spread="0.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sham or Active LFMS (two-night average)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.75" spread="0.82"/>
                    <measurement group_id="O2" value="2.75" spread="1.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline SQS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.85" spread="0.71"/>
                    <measurement group_id="O2" value="0.85" spread="1.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of SQS for active/sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to:
H0: Mean changes from Baseline SQS for active/sham LFMS are equal Ha: Means differ</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>1.00</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of SQS for Baseline and Active LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline SQS for Active LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.004</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of SQS for Baseline and Sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline SQS for Sham LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.042</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Awakenings (#Awake) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
        <description>Number of Awakenings (#awake) is the integer number of nocturnal awakenings after initial sleep onset, i.e. a count.</description>
        <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
        <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
        <group_list>
          <group group_id="O1">
            <title>Active Low Field Magnetic Stimulation</title>
            <description>LFMS - Active
LFMS - Active: A non-invasive form of brain stimulation administered from a device resembling a bird cage. The device covers the top part of the head for the duration of stimulation (in the current study, 20 minutes)</description>
          </group>
          <group group_id="O2">
            <title>Sham Low Field Magnetic Stimulation</title>
            <description>LFMS - Sham
LFMS - Sham: A simulation of the LFMS-Active intervention, using the same device that produces a sound similar to the sound made by the device during the active treatment, for a similar duration (in the current study, 20 minutes)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Awakenings (#Awake) After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
          <description>Number of Awakenings (#awake) is the integer number of nocturnal awakenings after initial sleep onset, i.e. a count.</description>
          <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
          <units>awakenings</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline #awake</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" spread="8.31"/>
                    <measurement group_id="O2" value="19" spread="8.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sham or Active LFMS (two-night average)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.45" spread="5.36"/>
                    <measurement group_id="O2" value="21.17" spread="8.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline #awake</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.55" spread="5.30"/>
                    <measurement group_id="O2" value="2.50" spread="6.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of #awake for active/sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to:
H0: Mean changes from Baseline #awake for active/sham LFMS are equal Ha: Means differ</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of #awake for Baseline and Active LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline #awake for Active LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.379</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of #awake for Baseline and Sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline #awake for Sham LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.284</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fatigue After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
        <description>Participants rate after each night how fatigued they feel on a 0-100mm continuous scale; 0mm not at all; 100mm very/a lot.</description>
        <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
        <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
        <group_list>
          <group group_id="O1">
            <title>Active Low Field Magnetic Stimulation</title>
            <description>LFMS - Active
LFMS - Active: A non-invasive form of brain stimulation administered from a device resembling a bird cage. The device covers the top part of the head for the duration of stimulation (in the current study, 20 minutes)</description>
          </group>
          <group group_id="O2">
            <title>Sham Low Field Magnetic Stimulation</title>
            <description>LFMS - Sham
LFMS - Sham: A simulation of the LFMS-Active intervention, using the same device that produces a sound similar to the sound made by the device during the active treatment, for a similar duration (in the current study, 20 minutes)</description>
          </group>
        </group_list>
        <measure>
          <title>Fatigue After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
          <description>Participants rate after each night how fatigued they feel on a 0-100mm continuous scale; 0mm not at all; 100mm very/a lot.</description>
          <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
          <units>units on a scale (0-100mm)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline fatigue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.10" spread="24.73"/>
                    <measurement group_id="O2" value="58.10" spread="24.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sham or Active LFMS (two-night average)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.65" spread="22.30"/>
                    <measurement group_id="O2" value="45.45" spread="27.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline fatigue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.45" spread="11.13"/>
                    <measurement group_id="O2" value="-12.65" spread="23.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of Fatigue for active/sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to:
H0: Mean changes from Baseline Fatigue for active/sham LFMS are equal Ha: Means differ</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.226</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of Fatigue for Baseline and Active LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline Fatigue for Active LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.156</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of Fatigue for Baseline and Sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline Fatigue for Sham LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.117</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Concentration After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
        <description>Participants rate after each night their ability to concentrate on a 0-100mm continuous scale; 0mm not at all; 100mm very/a lot. This is a subjective proxy measure for a restorative sleep / sleep quality.</description>
        <time_frame>Each night (5 nights total): Baseline (adaptation night #1), First Intervention (nights #2,#3), Second Intervention (nights #4,#5); Interventions randomized Sham or Active LFMS</time_frame>
        <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
        <group_list>
          <group group_id="O1">
            <title>Active Low Field Magnetic Stimulation</title>
            <description>LFMS - Active
LFMS - Active: A non-invasive form of brain stimulation administered from a device resembling a bird cage. The device covers the top part of the head for the duration of stimulation (in the current study, 20 minutes)</description>
          </group>
          <group group_id="O2">
            <title>Sham Low Field Magnetic Stimulation</title>
            <description>LFMS - Sham
LFMS - Sham: A simulation of the LFMS-Active intervention, using the same device that produces a sound similar to the sound made by the device during the active treatment, for a similar duration (in the current study, 20 minutes)</description>
          </group>
        </group_list>
        <measure>
          <title>Concentration After Sham vs. Active LFMS (Each Averages of Two Consecutive Nights); and Difference From Baseline (Adaptation Night)</title>
          <description>Participants rate after each night their ability to concentrate on a 0-100mm continuous scale; 0mm not at all; 100mm very/a lot. This is a subjective proxy measure for a restorative sleep / sleep quality.</description>
          <population>12 subjects completed the adaptation night (Baseline); 1 subject was then excluded due to mild sleep apnea; 11 subjects completed treatment (active or sham) nights 1/2; 1 subject moved out of State (received sham in night 1/2); 10 subjects completed all 5 nights: adaptation night and intervention nights 2/3 &amp; 4/5, each pair either sham or active.</population>
          <units>units on a scale (0-100mm)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline concentration</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.80" spread="22.42"/>
                    <measurement group_id="O2" value="46.80" spread="22.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sham or Active LFMS (two-night average)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.40" spread="19.58"/>
                    <measurement group_id="O2" value="36.80" spread="20.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline concentration</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.40" spread="11.28"/>
                    <measurement group_id="O2" value="-10.00" spread="18.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of Concentration for active/sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to:
H0: Mean changes from Baseline Concentration for active/sham LFMS are equal Ha: Means differ</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.130</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of Concentration for Baseline and Active LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline Concentration for Active LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.249</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This is a crossover study; we use a paired t-test to test the hypothesis:
H0: Means of Concentration for Baseline and Sham LFMS are equal Ha: Means differ
Note this paired t-test is equivalent to a one-sample t-test:
H0: Mean changes from Baseline Concentration for Sham LFMS is equal 0 Ha: Mean is not equal zero</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Significance level alpha=0.05; CI=95%</non_inferiority_desc>
            <p_value>0.114</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Beginning with the baseline adaptation night adverse effect were actively monitored over the duration of the study interventions (distributed over approx. two weeks for each subject); monitoring specifically included all 5 nights spent in the sleep lab (adaptation night #1, first intervention nights 2&amp;3, washout period, and second intervention nights 4&amp;5)</time_frame>
      <desc>Each study participant was further informed that adverse effects, should they occur outside the active monitoring period and/or after the study concluded, can be reported directly to either the sleep-lab manager, to the attending physician (T. Uhde), or to the clinical psychologist (A. Wilkerson).</desc>
      <group_list>
        <group group_id="E1">
          <title>Entire Study Population</title>
          <description>All participants completed an adaptation night (night #1) in the sleep lab including baseline assessment. Participants were treatment randomized to receive, after the adaptation night in the sleep lab, either two consecutive nights (night #2,#3) of &quot;Active Low Field Magnetic Stimulation&quot; followed by two consecutive nights (night #4,#5) of &quot;Sham Low Field Magnetic Stimulation&quot;, or vice versa. A washout period was permitted between nights #3 and #4 when the intervention changed.
Interventions:
Active Low Field Magnetic Stimulation A non-invasive form of brain stimulation administered from a device resembling a bird cage. The device covers the top part of the head for the duration of stimulation (20 minutes before sleep)
Sham Low Field Magnetic Stimulation A simulation of the LFMS-Active intervention, using the same device that produces a sound similar to the sound made by the device during the active treatment, for a similar duration (20 minutes before sleep)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Thomas W. Uhde, M.D.</name_or_title>
      <organization>Medical University of South Carolina</organization>
      <phone>843-792-0028</phone>
      <email>uhde@musc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

